The presence of industrial c'/> High-throughput in Vitro Data To Inform Prioritization of Ambient Water Monitoring and Testing for Endocrine Active Chemicals
首页> 外文期刊>Environmental Science & Technology >High-throughput in Vitro Data To Inform Prioritization of Ambient Water Monitoring and Testing for Endocrine Active Chemicals
【24h】

High-throughput in Vitro Data To Inform Prioritization of Ambient Water Monitoring and Testing for Endocrine Active Chemicals

机译:高通量的体外数据可为环境水监测和内分泌活性化学品的测试提供优先顺序

获取原文
获取原文并翻译 | 示例
           

摘要

src="http://pubs.acs.org/appl/literatum/publisher/achs/journals/content/esthag/2018/esthag.2018.52.issue-2/acs.est.7b00014/20180111/images/medium/es-2017-000143_0007.gif">The presence of industrial chemicals, consumer product chemicals, and pharmaceuticals is well documented in waters in the U.S. and globally. Most of these chemicals lack health-protective guidelines and many have been shown to have endocrine bioactivity. There is currently no systematic or national prioritization for monitoring waters for chemicals with endocrine disrupting activity. We propose ambient water bioactivity concentrations (AWBCs) generated from high throughput data as a health-based screen for endocrine bioactivity of chemicals in water. The U.S. EPA ToxCast program has screened over 1800 chemicals for estrogen receptor (ER) and androgen receptor (AR) pathway bioactivity. AWBCs are calculated for 110 ER and 212 AR bioactive chemicals using high throughput ToxCast data from in vitro screening assays and predictive pathway models, high-throughput toxicokinetic data, and data-driven assumptions about consumption of water. Chemical-specific AWBCs are compared with measured water concentrations in data sets from the greater Denver area, Minnesota lakes, and Oregon waters, demonstrating a framework for identifying endocrine bioactive chemicals. This approach can be used to screen potential cumulative endocrine activity in drinking water and to inform prioritization of future monitoring, chemical testing and pollution prevention efforts.
机译:src =“ http://pubs.acs.org/appl/literatum/publisher/achs/journals/content/esthag/2018/esthag.2018.52.issue-2/acs.est.7b00014/20180111/images/medium /es-2017-000143_0007.gif“>在美国和全球的水域中,有据可查的是工业化学品,消费品化学品和药品的存在。这些化学物质大多数缺乏健康保护准则,许多化学物质已显示具有内分泌生物活性。目前,尚无系统或全国性的优先事项来监测水域中具有内分泌干扰活性的化学物质。我们建议从高通量数据中产生的环境水生物活性浓度(AWBCs),作为基于健康的筛查水中化学物质内分泌生物活性的方法。美国EPA ToxCast计划已针对雌激素受体(ER)和雄激素受体(AR)途径的生物活性筛选了1800多种化学物质。使用来自体外筛选测定和预测性途径模型的高通量ToxCast数据,高通量毒物代谢动力学数据以及数据驱动的水消耗假设来计算110 ER和212 AR生物活性化学品的AWBC。在更大的丹佛地区,明尼苏达州湖泊和俄勒冈州水域的数据集中,将特定于化学物质的AWBC与测得的水浓度进行比较,证明了鉴定内分泌生物活性化学品的框架。该方法可用于筛选饮用水中潜在的累积内分泌活动,并为将来的监测,化学测试和污染预防工作提供优先次序。

著录项

  • 来源
    《Environmental Science & Technology》 |2018年第2期|783-793|共11页
  • 作者单位

    Boston University School of Public Health, 715 Albany St. Boston, Massachusetts 02118, United States;

    Oak Ridge Institute of Science and Education, Oak Ridge, Tennessee United States;

    DJD Consulting, PO Box 4518, Paso Robles, California 93447, United States;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号